FDA Investigator

Harshal J Desai

Latest inspection on record: Cherryville, United States, March 2024 · records back to 2021

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 17 inspections across 17 sites are on record.
  • 38 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2024-03-08.

At a glance

Inspections

17

Sites

17

Observations

38

Career since

Aug 2021

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Active Intelligence, LLC8 Mar 2024Human DrugsView 483 →
Colgate-Palmolive Company11 Jan 2024Human Drugs
Diversey Canada, Inc9 Nov 2023Human DrugsView 483 →
Teva Canada Limited3 Nov 2023Human Drugs
Brands International Corporation27 Oct 2023Human DrugsView 483 →

Sites inspected

Active Intelligence, LLCCherryville, United States1 insp.
Colgate-Palmolive CompanyMorristown, United States1 insp.
Diversey Canada, IncLondon, Canada1 insp.
Teva Canada LimitedStouffville, Canada1 insp.
Brands International CorporationNewmarket, Canada1 insp.

Co-investigators

Investigators who share inspections with this person.

Megan T Ziegler1 shared
Regan T Harp1 shared
Martrice A Packer1 shared
Navista C Bolton1 shared

Full investigator report

Get the verbatim findings behind Harshal J Desai's 38 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site